I-131, I-123, and F-18 FDG-PET imaging in a patient with diffuse sclerosing variant of papillary thyroid cancer

Clinical Nuclear Medicine

Volumn 33, Issue 12, 2008, Pages 834-837

  Wong, Terence Z ^a,b   Jain, Manoj K ^a   Spratt, Susan E ^b  

^a Division of Nuclear Medicine   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bipolar disorder; Fluorodeoxyglucose; Neck; Radioiodine therapy; Scintigraphy; Sodium iodide

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINE 123; LITHIUM CARBONATE; SODIUM IODIDE I 131; DIAGNOSTIC AGENT; FLUORINE; RADIOACTIVE IODINE;

ADULT; ARTICLE; BIPOLAR DISORDER; CANCER LOCALIZATION; CASE REPORT; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; POSITRON EMISSION TOMOGRAPHY; RADIOISOTOPE DISTRIBUTION; RADIOISOTOPE THERAPY; THYROID PAPILLARY CARCINOMA; WHOLE BODY SCINTISCANNING; COMPUTER ASSISTED TOMOGRAPHY; METASTASIS; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; PAPILLARY CARCINOMA; SCINTISCANNING; THYROID TUMOR;

CARCINOMA, PAPILLARY; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; IODINE RADIOISOTOPES; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM, RESIDUAL; POSITRON-EMISSION TOMOGRAPHY; THYROID NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 58749088411     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31818bf135     Document Type: Article

References (7)

1. Carcangiu ML, Bianchi S. Diffuse sclerosing variant of papillary thyroid carcinoma. Clinicopathologic study of 15 cases. Am J Surg Pathol. 1989;13:1041-1049.
2. Chow SM, Chan JK, Law SC, et al. Diffuse sclerosing variant of papillary thyroid carcinoma-clinical features and outcome. Eur J Surg Oncol. 2003;29:446-449.
3. Temple R, Berman M, Robbins J, et al. The use of lithium in the treatment of thyrotoxicosis. J Clin Invest. 1972;51:2746-2756.
4. Koong SS, Reynolds JC, Movius EG, et al. Lithium as a potential adjuvant to 131-I therapy of metastatic, well differentiated thyroid carcinoma. J Clin Endocrinol Metab. 1999;84:912-916.
5. Pons F, Carrio I, Estorch M, et al. Lithium as an adjuvant of iodine-131 uptake when treating patients with well-differentiated thyroid carcinoma. Clin Nucl Med. 1987;12:644-647.
6. Mandel SJ, Shankar LK, Benard F, et al. Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer. Clin Nucl Med. 2001;26:6-9.
7. Klein HA, DiSibio KJ, Sims D, et al. I-123 whole body scanning: case report and discussion. Clin Nucl Med. 2005;30:312-316.